Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
It is a synthetic fragment of human growth hormone (amino acids 176-191), studied in research settings for its proposed role in fat metabolism
Originally developed by Metabolic Pharmaceuticals in Australia during the 1990s, this synthetic peptide was designed to harness growth hormones fat-mobilizing properties while avoiding the metabolic complications associated with full-length GH therapy
Weeks 46 in informal reports : some community accounts describe early waist or body-fat changes, but other causes cannot be ruled out
NNMT Inhibition and Intracellular Signaling The primary mechanism of 5-AMINO-1MQ 10MG involves the potent, selective inhibition of the NNMT enzyme, which is often overexpressed in metabolic disorders
From the ASV table (Supplementary Table S1), sums of ASVs within each respective phylum or genus for each sample were calculated to establish the abundance of each phylum or genus per sample
Sci Rep 12 , 484 (2022)
